Rise Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Rise Advisors's MRK Position: Q3 2026 in Review
Rise Advisors reduced its Merck (MRK) stake by 47% in Q3 2026, selling an estimated $180K and leaving 1,492 shares worth $217K. The position accounts for 0.06% of the portfolio, ranked #96.
Rise Advisors first reported a position in MRK in Q4 2021 and has held it in 20 quarters since. The position peaked at $653K in Q2 2024. 3,979 funds tracked by Wall St. Rank hold MRK as of Q3 2026.
- Rise Advisors held 1,492 shares of Merck worth $217K as of Q3 2026.
- Rise Advisors sold 1,302 Merck shares in Q3 2026, an estimated $180K.
- Merck made up 0.06% of Rise Advisors's portfolio in Q3 2026, its #96 holding.
- Rise Advisors first reported a position in Merck in Q4 2021 and has held it in 20 quarters since.
- Rise Advisors's Merck position peaked at $653K in Q2 2024.
- 3,979 funds tracked by Wall St. Rank held Merck as of Q3 2026.
Based on Rise Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.